194 related articles for article (PubMed ID: 10543741)
1. Chemoprophylaxis of influenza A virus infections, with single doses of zanamivir, demonstrates that zanamivir is cleared slowly from the respiratory tract.
Fenton RJ; Morley PJ; Owens IJ; Gower D; Parry S; Crossman L; Wong T
Antimicrob Agents Chemother; 1999 Nov; 43(11):2642-7. PubMed ID: 10543741
[TBL] [Abstract][Full Text] [Related]
2. GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is a potent inhibitor of influenza virus in ferrets.
Ryan DM; Ticehurst J; Dempsey MH
Antimicrob Agents Chemother; 1995 Nov; 39(11):2583-4. PubMed ID: 8585752
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase).
Ryan DM; Ticehurst J; Dempsey MH; Penn CR
Antimicrob Agents Chemother; 1994 Oct; 38(10):2270-5. PubMed ID: 7840556
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of zanamivir against avian influenza A viruses that possess genes encoding H5N1 internal proteins and are pathogenic in mammals.
Leneva IA; Goloubeva O; Fenton RJ; Tisdale M; Webster RG
Antimicrob Agents Chemother; 2001 Apr; 45(4):1216-24. PubMed ID: 11257037
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection.
Mendel DB; Tai CY; Escarpe PA; Li W; Sidwell RW; Huffman JH; Sweet C; Jakeman KJ; Merson J; Lacy SA; Lew W; Williams MA; Zhang L; Chen MS; Bischofberger N; Kim CU
Antimicrob Agents Chemother; 1998 Mar; 42(3):640-6. PubMed ID: 9517945
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.
Hayden FG; Osterhaus AD; Treanor JJ; Fleming DM; Aoki FY; Nicholson KG; Bohnen AM; Hirst HM; Keene O; Wightman K
N Engl J Med; 1997 Sep; 337(13):874-80. PubMed ID: 9302301
[TBL] [Abstract][Full Text] [Related]
7. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides.
Smith PW; Sollis SL; Howes PD; Cherry PC; Starkey ID; Cobley KN; Weston H; Scicinski J; Merritt A; Whittington A; Wyatt P; Taylor N; Green D; Bethell R; Madar S; Fenton RJ; Morley PJ; Pateman T; Beresford A
J Med Chem; 1998 Mar; 41(6):787-97. PubMed ID: 9526555
[TBL] [Abstract][Full Text] [Related]
8. Zanamivir: from drug design to the clinic.
Elliott M
Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1885-93. PubMed ID: 11779388
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of once daily intranasal zanamivir in preventing experimental human influenza A infection.
Calfee DP; Peng AW; Hussey EK; Lobo M; Hayden FG
Antivir Ther; 1999; 4(3):143-9. PubMed ID: 12731753
[TBL] [Abstract][Full Text] [Related]
10. Zanamivir.
Waghorn SL; Goa KL
Drugs; 1998 May; 55(5):721-5; discussion 725-7. PubMed ID: 9585868
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir.
Bantia S; Parker CD; Ananth SL; Horn LL; Andries K; Chand P; Kotian PL; Dehghani A; El-Kattan Y; Lin T; Hutchison TL; Montgomery JA; Kellog DL; Babu YS
Antimicrob Agents Chemother; 2001 Apr; 45(4):1162-7. PubMed ID: 11257030
[TBL] [Abstract][Full Text] [Related]
12. Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses.
Govorkova EA; Leneva IA; Goloubeva OG; Bush K; Webster RG
Antimicrob Agents Chemother; 2001 Oct; 45(10):2723-32. PubMed ID: 11557461
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.
Sidwell RW; Huffman JH; Barnard DL; Bailey KW; Wong MH; Morrison A; Syndergaard T; Kim CU
Antiviral Res; 1998 Feb; 37(2):107-20. PubMed ID: 9588843
[TBL] [Abstract][Full Text] [Related]
14. Direct measurement of the anti-influenza agent zanamivir in the respiratory tract following inhalation.
Peng AW; Milleri S; Stein DS
Antimicrob Agents Chemother; 2000 Jul; 44(7):1974-6. PubMed ID: 10858364
[TBL] [Abstract][Full Text] [Related]
15. Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza.
Macdonald SJ; Cameron R; Demaine DA; Fenton RJ; Foster G; Gower D; Hamblin JN; Hamilton S; Hart GJ; Hill AP; Inglis GG; Jin B; Jones HT; McConnell DB; McKimm-Breschkin J; Mills G; Nguyen V; Owens IJ; Parry N; Shanahan SE; Smith D; Watson KG; Wu WY; Tucker SP
J Med Chem; 2005 Apr; 48(8):2964-71. PubMed ID: 15828835
[TBL] [Abstract][Full Text] [Related]
16. Assessment of development of resistance to antivirals in the ferret model of influenza virus infection.
Herlocher ML; Truscon R; Fenton R; Klimov A; Elias S; Ohmit SE; Monto AS
J Infect Dis; 2003 Nov; 188(9):1355-61. PubMed ID: 14593594
[TBL] [Abstract][Full Text] [Related]
17. Zanamivir: an influenza virus neuraminidase inhibitor.
Colman PM
Expert Rev Anti Infect Ther; 2005 Apr; 3(2):191-9. PubMed ID: 15918777
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza.
Hayden FG; Treanor JJ; Betts RF; Lobo M; Esinhart JD; Hussey EK
JAMA; 1996 Jan 24-31; 275(4):295-9. PubMed ID: 8544269
[TBL] [Abstract][Full Text] [Related]
19. Treating influenza with zanamivir.
Fleming DM
Lancet; 1999 Feb; 353(9153):668-9. PubMed ID: 10030349
[No Abstract] [Full Text] [Related]
20. Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives.
Masuda T; Yoshida S; Arai M; Kaneko S; Yamashita M; Honda T
Chem Pharm Bull (Tokyo); 2003 Dec; 51(12):1386-98. PubMed ID: 14646315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
